Brief Information of the Cell Line and Protein
Cell Line ID: CL001047 , HEK293T-ARRB1
Category Transformed cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0063
Protein ID: PT01909 , Neuropeptide Y receptor type 4
Gene Name NPY4R
Organism Homo sapiens, Human
Protein Classification Membrane receptor
Uniprot ID P50391
Table of Molecular Bioactivities Related to the Cell Line and Protein
Cell Line ID: CL001047  Protein ID: PT01909
 
Compound ID Compound Name Compound Formula
CP0868331
(9S,12S,15S)-12-((1H-indol-3-yl)methyl)-N-((S)-1-((S)-1-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-4-methyl-1-oxopentan-2-yl)-15-(3-guanidinopropyl)-4-imino-2,11,14,17,20-pentaoxo-1,3,5,10,13,16,21-heptaazacyclopentacosane-9-carboxamide
   Show/Hide
C53H81N19O10
 1
1
EC50 = 1 nM
   TI
   LI
   LO
   TS
CP0868314
(13R,16R,19R)-1-amino-13-((R)-1-((R)-1-((R)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylamino)-5-guanidino-1-oxopentan-2-ylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-ylcarbamoyl)-19-(3-guanidinopropyl)-16-(4-hydroxybenzyl)-8-imino-6,15,18,21-tetraoxo-5,7,9,14,17,20-hexaazatetracosan-24-oic acid
   Show/Hide
C56H81N19O12
 1
1
EC50 = 85.11 nM
   TI
   LI
   LO
   TS
CP0868315
(6S,9S,12S,15S,18S)-9-((1H-indol-3-yl)methyl)-1-amino-6-((S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-ylcarbamoyl)-12-(3-(3-(3-aminopropylcarbamoyl)guanidino)propyl)-18-(3-guanidinopropyl)-15-(4-hydroxybenzyl)-1-imino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazatricosan-23-oic acid
   Show/Hide
C55H79N19O12
 1
1
EC50 = 123.03 nM
   TI
   LI
   LO
   TS
CP0418613
(15S,18S,21S,24S,27S)-2-amino-N-[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]-15,21-bis[3-(diaminomethylideneamino)propyl]-18-[(4-hydroxyphenyl)methyl]-24-(2-methylpropyl)-4,10,13,16,19,22,25-heptaoxo-1,3,5,9,14,17,20,23,26-nonazacyclotriacontene-27-carboxamide
   Show/Hide
C50H78N18O11
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0451151
4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-[[amino-(3-aminopropylcarbamoylamino)methylidene]amino]-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid
   Show/Hide
C50H80N18O12
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0451152
(5R,8S,11S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-5,8-bis[3-(diaminomethylideneamino)propyl]-3,6,9,14-tetraoxo-1,4,7,10-tetrazacyclotetradecane-11-carboxamide
   Show/Hide
C40H67N17O9
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0531386
(5R,8S,11S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-amino-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-5,8-bis[3-(diaminomethylideneamino)propyl]-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridecane-11-carboxamide
   Show/Hide
C39H65N17O9
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS